Dexrazoxane Intravenous and Kisqali Femara Co-Pack 600 mg-2.5 mg Dose
Determining the interaction of Dexrazoxane Intravenous and Kisqali Femara Co-Pack 600 mg-2.5 mg Dose and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: dexrazoxane
Brand name: Totect, Zinecard
Synonyms: Dexrazoxane
Generic Name: letrozole / ribociclib
Brand name: Kisqali Femara Co-Pack 200 mg-25 mg Dose, Kisqali Femara Co-Pack 400 mg-25 mg Dose, Kisqali Femara Co-Pack 600 mg-25 mg Dose
Synonyms: Kisqali Femara Co-Pack 200 mg-2.5 mg Dose, Kisqali Femara Co-Pack
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Dexrazoxane Intravenous-Kitabis Pak
- Dexrazoxane Intravenous-Kitabis Pak inhalation
- Dexrazoxane Intravenous-Klofensaid II
- Dexrazoxane Intravenous-Klonopin
- Dexrazoxane Intravenous-Klonopin Wafer
- Dexrazoxane Intravenous-Klonopin Wafers
- Kisqali Femara Co-Pack 600 mg-2.5 mg Dose-Dextenza Insert
- Kisqali Femara Co-Pack 600 mg-2.5 mg Dose-Dextenza intraocular
- Kisqali Femara Co-Pack 600 mg-2.5 mg Dose-Dextran 40
- Kisqali Femara Co-Pack 600 mg-2.5 mg Dose-Dextran 70 6% in 5% Dextrose high molecular weight
- Kisqali Femara Co-Pack 600 mg-2.5 mg Dose-Dextran 75
- Kisqali Femara Co-Pack 600 mg-2.5 mg Dose-Dextran high molecular weight